Histone H3.3 variant plays a critical role on zygote-to-oocyst development in malaria parasites.


Journal

Parasitology international
ISSN: 1873-0329
Titre abrégé: Parasitol Int
Pays: Netherlands
ID NLM: 9708549

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 15 12 2023
revised: 02 01 2024
accepted: 02 01 2024
medline: 18 3 2024
pubmed: 11 1 2024
entrez: 10 1 2024
Statut: ppublish

Résumé

The Plasmodium life cycle involves differentiation into multiple morphologically distinct forms, a process regulated by developmental stage-specific gene expression. Histone proteins are involved in epigenetic regulation in eukaryotes, and the histone variant H3.3 plays a key role in the regulation of gene expression and maintenance of genomic integrity during embryonic development in mice. However, the function of H3.3 through multiple developmental stages in Plasmodium remains unknown. To examine the function of H3.3, h3.3-deficient mutants (Δh3.3) were generated in P. berghei. The deletion of h3.3 was not lethal in blood stage parasites, although it had a minor effect of the growth rate in blood stage; however, the in vitro ookinete conversion rate was significantly reduced, and the production of the degenerated form was increased. Regarding the mosquito stage development of Δh3.3, oocysts number was significantly reduced, and no sporozoite production was observed. The h3.3 gene complemented mutant have normal development in mosquito stage producing mature oocysts and salivary glands contained sporozoites, and interestingly, the majority of H3.3 protein was detected in female gametocytes. However, Δh3.3 male and female gametocyte production levels were comparable to the wild-type levels. Transcriptome analysis of Δh3.3 male and female gametocytes revealed the upregulation of several male-specific genes in female gametocytes, suggesting that H3.3 functions as a transcription repressor of male-specific genes to maintain sexual identity in female gametocytes. This study provides new insights into the molecular biology of histone variants H3.3 which plays a critical role on zygote-to-oocyst development in primitive unicellular eukaryotes.

Identifiants

pubmed: 38199522
pii: S1383-5769(24)00007-2
doi: 10.1016/j.parint.2024.102856
pii:
doi:

Substances chimiques

Histones 0
Protozoan Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102856

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Auteurs

Yuki S Tateishi (YS)

Department of Parasitology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (IMSUT), Minato-ku, Tokyo, Japan; Graduate School of Frontier Sciences, Department of Computational Biology and Medical Science (CBMS), University of Tokyo, Tokyo, Japan.

Tamasa Araki (T)

Department of Parasitology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.

Satoru Kawai (S)

Department of Tropical Medicine and Parasitology, Dokkyo Medical University, Mibu, Tochigi, Japan.

Shuhei Koide (S)

Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.

Yuko Umeki (Y)

Department of Parasitology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan; Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.

Takashi Imai (T)

Department of Parasitology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan; Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.

Yumiko Saito-Nakano (Y)

Department of Parasitology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan; Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.

Masaki Kikuchi (M)

Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research, Yokohama, Kanagawa, Japan.

Atsushi Iwama (A)

Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan.

Hajime Hisaeda (H)

Department of Parasitology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.

Cevayir Coban (C)

Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (IMSUT), Minato-ku, Tokyo, Japan; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan; International Vaccine Design Center (vDesC), The Institute of Medical Science, The University of Tokyo (IMSUT), Minato-ku, Tokyo, Japan.

Takeshi Annoura (T)

Department of Parasitology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan. Electronic address: annoura@niid.go.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH